Tyra Biosciences, Inc. (TYRA)
NASDAQ: TYRA · Real-Time Price · USD
33.75
-1.29 (-3.68%)
At close: Mar 9, 2026, 4:00 PM EDT
33.50
-0.25 (-0.74%)
After-hours: Mar 9, 2026, 6:55 PM EDT

Tyra Biosciences Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025 FY 2024 FY 2023 FY 2022 FY 2021 2020 - 2019
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 2020 - 2019
Net Income
-119.95-86.48-69.13-55.33-26.29
Upgrade
Depreciation & Amortization
0.550.520.360.30.14
Upgrade
Loss (Gain) From Sale of Assets
---00
Upgrade
Loss (Gain) From Sale of Investments
-2.12-5.88-1.25--
Upgrade
Stock-Based Compensation
28.0122.813.5310.592.89
Upgrade
Change in Accounts Payable
3.37-0.749.372.361.49
Upgrade
Change in Other Net Operating Assets
-50.02-3.01-8.2-1.97
Upgrade
Operating Cash Flow
-95.14-69.77-50.14-50.29-23.75
Upgrade
Capital Expenditures
-0.14-0.66-0.77-0.56-0.66
Upgrade
Sale of Property, Plant & Equipment
----0.02
Upgrade
Investment in Securities
72.6-97.74-143.84--
Upgrade
Investing Cash Flow
72.46-98.4-144.61-0.56-0.65
Upgrade
Long-Term Debt Repaid
-----0.01
Upgrade
Net Debt Issued (Repaid)
-----0.01
Upgrade
Issuance of Common Stock
8.1202.561.540.63181.73
Upgrade
Other Financing Activities
--0.42---
Upgrade
Financing Cash Flow
8.1202.141.540.63311.35
Upgrade
Net Cash Flow
-14.5833.96-193.21-50.21286.96
Upgrade
Free Cash Flow
-95.28-70.44-50.91-50.84-24.41
Upgrade
Free Cash Flow Per Share
-1.60-1.23-1.19-1.21-1.77
Upgrade
Cash Interest Paid
----1.24
Upgrade
Levered Free Cash Flow
-54.55-41.15-29.49-28.56-14.18
Upgrade
Unlevered Free Cash Flow
-54.55-41.15-29.49-28.56-14.18
Upgrade
Change in Working Capital
-1.63-0.736.36-5.85-0.48
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.